Thermo Fisher (TMO) is a publicly traded Healthcare sector company. As of July 15, 2026, TMO trades at $531.55 with a market cap of $196.41B and a P/E ratio of 29.36. TMO moved +1.05% today. Year to date, TMO is -7.83%; over the trailing twelve months it is +25.56%. Its 52-week range spans $385.46 to $643.99. Analyst consensus is strong buy with an average price target of $587.44. Rallies surfaces TMO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks TMO insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $531.55 |
| Market Cap | $196.41B |
| P/E Ratio | 29.36 |
| EPS | $18.22 |
| Dividend Yield | 0.47% |
| 52-Week High | $643.99 |
| 52-Week Low | $385.46 |
| Volume | 1.73M |
| Avg Volume | 0 |
| Revenue (TTM) | $45.20B |
| Net Income | $6.87B |
| Gross Margin | 0.00% |
21 analysts cover TMO: 0 strong buy, 16 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $587.44.